Article | February 24, 2025

Double, Double, Experts Huddle, Cells And Bioprocess Bubble

Source: RoosterBio

Any sufficiently advanced technology is indistinguishable from magic," wrote Arthur C. Clarke. While the biomanufacturing of therapeutic exosomes and extracellular vesicles (EVs) might still feel a bit like alchemy, RoosterBio and Repligen are working to ground it firmly in scientific process.

Facing rising demand for EVs in regenerative medicine and advanced therapeutics, the challenge of scalable, high-quality manufacturing is paramount. This article unpacks key insights from a joint webinar where experts from RoosterBio and Repligen detailed their collaborative approach. By integrating RoosterBio’s innovative upstream production with Repligen’s cutting-edge downstream purification, they're forging a streamlined bioprocess to overcome these hurdles.

Eager to understand how this powerful partnership is refining exosome and EV manufacturing? Uncover the critical insights and future possibilities – read the full article now.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online